0
TOOLS FOR GLYCOBIOLOGY
GLYCO-ENZYMES, RECOMBINANT PRODUCTS AND CUSTOM MAMMALIAN EXPRESSION SERVICES
CALL NOW
TOOLS FOR GLYCOBIOLOGY
GLYCO-ENZYMES, RECOMBINANT PRODUCTS AND
CUSTOM MAMMALIAN EXPRESSION SERVICES
SHOP NOW
CUSTOM MAMMALIAN EXPRESSION SERVICES
TOOLS FOR GLYCOBIOLOGY
GLYCO-ENZYMES, RECOMBINANT PRODUCTS AND
CUSTOM MAMMALIAN EXPRESSION SERVICES
SHOP NOW
CUSTOM MAMMALIAN EXPRESSION SERVICES
ABOUT GET, INC.
The GET team developed innovative technologies for high level expression of glycosylated recombinant products in mammalian cells for research and industry. The core product catalog includes an extensive collection of mammalian and bacterial Glyco-Enzymes (glycosyltransferases and glycoside hydrolases) and other recombinant glycoproteins. GET also provides scalable custom glycoprotein production through the use of proprietary expression vectors and mammalian cell lines.
Recombinant products generated by GET employ a proprietary Glo-Enzyme fusion protein strategy that provides efficient production and secretion in mammalian cells. The resulting products retain full enzymatic activity and can be quantified by fluorescence measurement. The technology also allows easy cleavage of fusion tags and remodeling of glycan structures on the recombinant products. The result is a flexible collection of Glyco-Enzymes and glycosylated products that are optimally suited for diverse biochemical, analytical, synthetic, cell biology and biotherapeutic applications.
About GET, Inc.
The GET team developed innovative technologies for high level expression of glycosylated recombinant products in mammalian cells for research and industry. The core product catalog includes an extensive collection of mammalian and bacterial Glyco-Enzymes (glycosyltransferases and glycoside hydrolases) and other recombinant glycoproteins. GET also provides scalable custom glycoprotein production through the use of proprietary expression vectors and mammalian cell lines.
Recombinant products generated by GET employ a proprietary Glo-Enzyme fusion protein strategy that provides efficient production and secretion in mammalian cells. The resulting products retain full enzymatic activity and can be quantified by fluorescence measurement. The technology also allows easy cleavage of fusion tags and remodeling of glycan structures on the recombinant products. The result is a flexible collection of Glyco-Enzymes and glycosylated products that are optimally suited for diverse biochemical, analytical, synthetic, cell biology and biotherapeutic applications.
Applications
ABOUT GET, INC
The GET team developed innovative technologies for high level expression of glycosylated recombinant products in mammalian cells for research and industry. The core product catalog includes an extensive collection of mammalian and bacterial Glyco-Enzymes (glycosyltransferases and glycoside hydrolases) and other recombinant glycoproteins. GET also provides scalable custom glycoprotein production through the use of proprietary expression vectors and mammalian cell lines.
Recombinant products generated by GET employ a proprietary Glo-Enzyme fusion protein strategy that provides efficient production and secretion in mammalian cells. The resulting products retain full enzymatic activity and can be quantified by fluorescence measurement. The technology also allows easy cleavage of fusion tags and remodeling of glycan structures on the recombinant products. The result is a flexible collection of Glyco-Enzymes and glycosylated products that are optimally suited for diverse biochemical, analytical, synthetic, cell biology and biotherapeutic applications.
Structure of human ST6GALNAC2 determined using recombinant expression strategies developed by GET, INC.
Applications
Product Highlights
A large collection of Glyco-Enzymes have been produced as Glo-Enzymes using the proprietary pGE series of expression vectors to provide robust production, secretion, and purification of highly active recombinant products
Applications in Cell Surface Tagging and Remodeling
Cell surface glycan remodeling and tagging of glycan structures has
been a significant application of the Glyco-Enzymes produced
using GET recombinant protein expression approaches.
Applications in Chemo-enzymatic Glycan Synthesis
Glyco-Enzymes produced using expression strategies employed
by GE -tech have been used in numerous chemo-enzymatic
synthesis applications.
Use in Structuraland Enzymatic Studies
Use in Structural
and Enzymatic Studies
Recombinant forms of the Glyco-Enzymes produced using GEtech
expression approaches have been employed for structural and
functional studies including enzymology, X-ray diffraction and NMR.
Structure of human ST6GALNAC2 determined using recombinant expression strategies developed by GET, INC.
Product Highlights
A large collection of Glyco-Enzymes have been produced as Glo-Enzymes using the proprietary pGE series of expression vectors to provide robust production, secretion, and purification of highly active recombinant products
Applications in Cell Surface Tagging and Remodeling
Publications of cell surface tagging applications using Glyco-Enzymes produced using GET recombinant protein expression technologies:
Applications in Chemo-enzymatic Glycan Synthesis
Chemo-enzymatic synthesis publications using Glyco-Enzymes produced using GET recombinant protein expression technologies:
Use in Structural
and Enzymatic Studies
and Enzymatic Studies
Protein structural studies using Glyco-Enzymes produced using GET recombinant protein expression technologies:
CONTACT INFO
QUICK LINKS
CONTACT US
Contact Us
Thank you for contacting us.
We will get back to you as soon as possible.
We will get back to you as soon as possible.
Oops, there was an error sending your message.
Please try again later.
Please try again later.
CONTACT INFO
QUICK LINKS
CONTACT US
Contact Us
Thank you for contacting us.
We will get back to you as soon as possible.
We will get back to you as soon as possible.
Oops, there was an error sending your message.
Please try again later.
Please try again later.
© Copyright 2018 | All Rights Reserved | Glyco Expression Technologies, Inc.
